Heart drug combo pill tested for easier dosing
NCT ID NCT07444164
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 trial tested whether a single capsule containing 90 mg ticagrelor and 100 mg aspirin works the same in the body as taking the two drugs separately. Twenty-four healthy adults in Mexico participated. The study measured how much of each drug reached the bloodstream and how fast the body cleared them.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ticagrelor and acetylsalicylic acid (aspirin) in a single capsule
- What this could lead to
- If successful, this could lead to a simpler, single-pill option for patients who need both ticagrelor and aspirin.
- What could go wrong
- This is an early-stage study in only 24 healthy people, so results may not predict how the drug works in patients or reveal all side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro de Estudios Científicos y Clínicos Pharma S.A. de C.V.
Xochitepec, Morelos, 627790, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test